Impaired cholecystokinin-induced gallbladder emptying incriminated in spontaneous “black” pigment gallstone formation in germfree Swiss Webster mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 308, Issue 4, 2015, Pages G335-G349

  Woods, Stephanie E ^a   Leonard, Monika R ^b   Hayden, Joshua A ^a   Brophy, Megan Brunjes ^a   Bernert, Kara R ^b   Lavoie, Brigitte ^c   Muthupalani, Sureshkumar ^a   Whary, Mark T ^a   Mawe, Gary M ^c   Nolan, Elizabeth M ^a   Carey, Martin C ^b   Fox, James G ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

Black pigment gallstones; Cholecystokinin; Germfree mice; Impaired gallbladder motility

Indexed keywords

BILIRUBIN; BILIRUBIN GLUCURONIDE; CHOLECYSTOKININ; CHOLESTEROL; GLUCOSE; BILE PIGMENT; CALCIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLACK PIGMENT GALLSTONE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EDEMA; ENTEROHEPATIC CIRCULATION; EPITHELIUM HYPERPLASIA; ERYTHROPOIESIS; FEMALE; GALLBLADDER EMPTYING; GALLBLADDER MOTILITY; GALLSTONE; GALLSTONE FORMATION; GLUCOSE BLOOD LEVEL; HEMOLYSIS; MALE; MOUSE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; AGE; ANIMAL; BODY WEIGHT; GALLBLADDER; GALLSTONES; GENETIC PREDISPOSITION; GENETICS; GERMFREE ANIMAL; METABOLISM; MUSCLE CONTRACTION; PATHOLOGY; PATHOPHYSIOLOGY; PH; SEX DIFFERENCE; SMOOTH MUSCLE; SPECIES DIFFERENCE; STATISTICAL MODEL; TIME FACTOR;

AGE FACTORS; ANIMALS; BILE PIGMENTS; BODY WEIGHT; CALCIUM; CHOLECYSTOKININ; FEMALE; GALLBLADDER; GALLSTONES; GENETIC PREDISPOSITION TO DISEASE; GERM-FREE LIFE; HYDROGEN-ION CONCENTRATION; LOGISTIC MODELS; MALE; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RISK FACTORS; SEX FACTORS; SPECIES SPECIFICITY; TIME FACTORS;

EID: 84922900598     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00314.2014     Document Type: Article

References (61)

1. Alam C, Bittoun E, Bhagwat D, Valkonen S, Saari A, Jaakkola U, Eerola E, Huovinen P, Hanninen A. Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice. Diabetologia 54: 1398–1406, 2011.
2. Balemba OB, Heppner TJ, Bonev AD, Nelson MT, Mawe GM. Calcium waves in intact guinea pig gallbladder smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 291: G717–G727, 2006.
3. Balemba OB, Salter MJ, Heppner TJ, Bonev AD, Nelson MT, Mawe GM. Spontaneous electrical rhythmicity and the role of the sarcoplasmic reticulum in the excitability of guinea pig gallbladder smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 290: G655–G664, 2006.
4. Cahalane MJ, Neubrand MW, Carey MC. Physical-chemical pathogen-esis of pigment gallstones. Semin Liver Dis 8: 317–328, 1988.
5. Chen CY, Lu CL, Huang YS, Tam TN, Chao Y, Chang FY, Lee SD. Age is one of the risk factors in developing gallstone disease in Taiwan. Age Ageing 27: 437–441, 1998.
6. Chia R, Achilli F, Festing MF, Fisher EM. The origins and uses of mouse outbred stocks. Nat Genet 37: 1181–1186, 2005.
7. Chikvaidze E, Tabutsadze T, Gogoladze T, Datuashvili G, Iremashvili B. Ternary complexes of albumin-Mn(II)-bilirubin and electron spin resonance studies of gallstones. Georgian Med News 168: 11–15, 2009.
8. Choi M, Moschetta A, Bookout AL, Peng L, Umetani M, Holmstrom SR, Suino-Powell K, Xu HE, Richardson JA, Gerard RD, Mangels-dorf DJ, Kliewer SA. Identification of a hormonal basis for gallbladder filling. Nat Med 12: 1253–1255, 2006.
9. Coates ME, Gustafsson editors BE. The Germ-free Animal in Biomed-ical Research. London: Laboratory Animals, 1984, p. 141–213, 291–332.
10. Cong P, Pricolo V, Biancani P, Behar J. Effects of cholesterol on CCK-1 receptors and caveolin-3 proteins recycling in human gallbladder muscle. Am J Physiol Gastrointest Liver Physiol 299: G742–G750, 2010.
11. Debray D, Rainteau D, Barbu V, Rouahi M, El Mourabit H, Lerondel S, Rey C, Humbert L, Wendum D, Cottart CH, Dawson P, Chignard N, Housset C. Defects in gallbladder emptying and bile acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies. Gastroenterology 142: 1581–1591, 2012.
12. Ding X, Lu CY, Mei Y, Liu CA, Shi YJ. Correlation between gene expression of CCK-A receptor and emptying dysfunction of the gallbladder in patients with gallstones and diabetes mellitus. Hepatobiliary Pan-creat Dis Int 4: 295–298, 2005.
13. Elek G, Rockenbauer A. The free radical signal of pigment gallstones. Klin Wochenschr 60: 33–35, 1982.
14. Everds NE. Hematology of the laboratory mouse. In: The Mouse in Biomedical Research: Normative Biology, Husbandry, and Models, edited by Fox JG, Barthold SW, Davisson MT, Newcomer CE, Quimby FW, Smith AL. San Diego, CA: Elsevier, 2007, p. 133–170.
15. Feldman M, Feldman M Jr. The incidence of cholelithiasis, cholester-osis, and liver disease in diabetes mellitus: an autopsy study. Diabetes 3: 305–307, 1954.
16. Fremont-Rahl JJ, Ge Z, Umana C, Whary MT, Taylor NS, Muthu-palani S, Carey MC, Fox JG, Maurer KJ. An analysis of the role of the indigenous microbiota in cholesterol gallstone pathogenesis. PLoS One 8: e70657, 2013.
17. Freudenberg F, Broderick AL, Yu BB, Leonard MR, Glickman JN, Carey MC. Pathophysiological basis of liver disease in cystic fibrosis employing a DeltaF508 mouse model. Am J Physiol Gastrointest Liver Physiol 294: G1411–G1420, 2008.
18. Freudenberg F, Leonard MR, Liu SA, Glickman JN, Carey MC. Pathophysiological preconditions promoting mixed “black” pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis. Am J Physiol Gastrointest Liver Physiol 299: G205–G214, 2010.
19. Ghumman CA, Moutinho AM, Santos A, Tolstogouzov A, Teodoro OM. TOF-SIMS study of cystine and cholesterol stones. J Mass Spectrom 47: 547–551, 2012.
20. Gomez-Pinilla PJ, Pozo MJ, Camello PJ. Aging impairs neurogenic contraction in guinea pig urinary bladder: role of oxidative stress and melatonin. Am J Physiol Regul Integr Comp Physiol 293: R793–R803, 2007.
21. Jacoby RO, Fox JG, Davisson M. Biology and diseases of mice. In: Laboratory Animal Medicine, edited by Fox JG, Anderson LC, Loew FM, Quimby FW. San Diego, CA: Elsevier, 2002, p. 43–44.
22. Katsika D, Grjibovski A, Einarsson C, Lammert F, Lichtenstein P, Marschall HU. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology 41: 1138–1143, 2005.
23. Kim IS, Myung SJ, Lee SS, Lee SK, Kim MH. Classification and nomenclature of gallstones revisited. Yonsei Med J 44: 561–570, 2003.
24. Kline LW, Karpinski E. Progesterone inhibits gallbladder motility through multiple signaling pathways. Steroids 70: 673–679, 2005.
25. Lavoie B, Balemba OB, Godfrey C, Watson CA, Vassileva G, Corvera CU, Nelson MT, Mawe GM. Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels. J Physiol 588: 3295–3305, 2010.
26. Lavoie B, Balemba OB, Nelson MT, Ward SM, Mawe GM. Morphological and physiological evidence for interstitial cell of Cajal-like cells in the guinea pig gallbladder. J Physiol 579: 487–501, 2007.
27. Lavoie B, Nausch B, Zane EA, Leonard MR, Balemba OB, Bartoo AC, Wilcox R, Nelson MT, Carey MC, Mawe GM. Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease. Neurogastroenterol Motil 24: e313–e324, 2012.
28. Lemke LB, Rogers AB, Nambiar PR, Fox JG. Obesity and non-insulin-dependent diabetes mellitus in Swiss-Webster mice associated with late-onset hepatocellular carcinoma. J Endocrinol 199: 21–32, 2008.
29. Le Roy T, Liopis M, Bruneau A, Rabot S, Bevilacqua C, Martin P, Walker F, Bado A, Perlemuter G, Cassard-Doulcier AM, Gerard P. Gut microbiota transplantation demonstrates its causal role in the development of type 2 diabetes and fatty liver. Abstract presented at the International Liver Congress 2012. Barcelona, Spain: 2012.
30. Levant JA, Kun TL, Jachna J, Sturdevant RA, Isenberg JI. The effects of graded doses of C-terminal octapeptide of cholecystokinin on small intestinal transit time in man. Am J Dig Dis 19: 207–209, 1974.
31. Martinez-Cuesta MA, Moreno L, Morillas J, Ponce J, Esplugues JV. Influence of cholecystitis state on pharmacological response to cholecysto-kinin of isolated human gallbladder with gallstones. Dig Dis Sci 48: 898–905, 2003.
32. Nakeeb A, Comuzzie AG, Martin L, Sonnenberg GE, Swartz-Basile D, Kissebah AH, Pitt HA. Gallstones: genetics versus environment. Ann Surg 235: 842–849, 2002.
33. Ostrow JD. The etiology of pigment gallstones. Hepatology 4: 215S–222S, 1984.
34. Pen J, Welling GW. The concentration of cholecystokinin in the intestinal tract of germ-free and control mice. Antonie Van Leeuwenhoek 47: 84–85, 1981.
35. Pen J, Welling GW. Influence of the microbial flora on the amount of CCK8- and secretin21-27-like immunoreactivity in the intestinal tract of mice. Comp Biochem Physiol B 76: 585–589, 1983.
36. Portincasa P, Di Ciaula A, Vendemiale G, Palmieri V, Moschetta A, Vanberge-Henegouwen GP, Palasciano G. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones. Eur J Clin Invest 30: 317–324, 2000.
37. Portincasa P, Di Ciaula A, Wang HH, Palasciano G, van Erpecum KJ, Moschetta A, Wang DQ. Coordinate regulation of gallbladder motor function in the gut-liver axis. Hepatology 47: 2112–2126, 2008.
38. Portincasa P, Moschetta A, Berardino M, Di-Ciaula A, Vacca M, Baldassarre G, Pietrapertosa A, Cammarota R, Tannoia N, Palas-ciano G. Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults. World J Gastroenterol 10: 2383–2390, 2004.
39. Quimby FW. The mouse In: The Clinical Chemistry of Laboratory Animals, edited by Loeb WF, Quimby FW. Philadelphia, PA: Taylor and Francis, 1999, p. 3–32.
40. Quimby FW, Luong RH. Clinical chemistry of the laboratory mouse. In: The Mouse in Biomedical Research: Normative Biology, Husbandry, and Models, edited by Fox JG, Barthold SW, Davisson MT, Newcomer CE, Quimby FW, Smith AL. San Diego, CA: Elsevier, 2007, p. 171–216.
41. Rogers AB, Boutin SR, Whary MT, Sundina N, Ge Z, Cormier K, Fox JG. Progression of chronic hepatitis and preneoplasia in Helicobacter hepaticus-infected A/JCr mice. Toxicol Pathol 32: 668–677, 2004.
42. Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, Angelin B, Hyotylainen T, Oresic M, Backhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17: 225–235, 2013.
43. Shiesh SC, Chen CY, Lin XZ, Liu ZA, Tsao HC. Melatonin prevents pigment gallstone formation induced by bile duct ligation in guinea pigs. Hepatology 32: 455–460, 2000.
44. Spivak W, Yuey W. Application of a rapid and efficient h.p.l.c. method to measure bilirubin and its conjugates from native bile and in model bile systems Potential use as a tool for kinetic reactions and as an aid in diagnosis of hepatobiliary disease. Biochem J 234: 101–109, 1986.
45. Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gas-troenterol Clin North Am 39: 157–169, 2010.
46. Stokes CS, Krawczyk M, Lammert F. Gallstones: environment, lifestyle and genes. Dig Dis 29: 191–201, 2011.
47. Su Y, Wu S, Fan Y, Jin J, Zhang Z. The preliminary experimental and clinical study of the relationship between the pigment gallstone and intestinal mucosal barrier. J Gastroenterol Hepatol 24: 1451–1456, 2009.
48. Trotman BW, Bernstein SE, Bove KE, Wirt GD. Studies on the pathogenesis of pigment gallstones in hemolytic anemia: description and characteristics of a mouse model. J Clin Invest 65: 1301–1308, 1980.
49. Tsunoda K, Shirai Y, Wakai T, Yokoyama N, Akazawa K, Hat-akeyama K. Increased risk of cholelithiasis after esophagectomy. J Hepatobiliary Pancreat Surg 11: 319–323, 2004.
50. van der Zee R, Welling GW. The effect of exogenous CCK-8 on the transit time and colonization resistance of decontaminated mice. Antonie Van Leeuwenhoek 47: 82–84, 1981.
51. van Erpecum KJ, Wang DQ, Moschetta A, Ferri D, Svelto M, Port-incasa P, Hendrickx JJ, Schipper M, Calamita G. Gallbladder histo-pathology during murine gallstone formation: relation to motility and concentrating function. J Lipid Res 47: 32–41, 2006.
52. Vercaemst R, Union A, Rosseneu M, De Craene I, De Backer G, Kornitzer M. Quantitation of plasma free cholesterol and cholesteryl esters by high performance liquid chromatography. Study of a normal population. Atherosclerosis 78: 245–250, 1989.
53. Vítek L, Carey MC. Enterohepatic cycling of bilirubin as a cause of ‘black’ pigment gallstones in adult life. Eur J Clin Invest 33: 799–810, 2003.
54. Vítek L, Carey MC. New pathophysiological concepts underlying patho-genesis of pigment gallstones. Clin Res Hepatol Gastroenterol 36: 122–129, 2012.
55. Vítek L, Ostrow JD. Bilirubin chemistry and metabolism; harmful and protective aspects. Curr Pharm Des 15: 2869–2883, 2009.
56. Vítek L, Zelenka J, Zadinova M, Malina J. The impact of intestinal microflora on serum bilirubin levels. J Hepatol 42: 238–243, 2005.
57. Wang DQ, Schmitz F, Kopin AS, Carey MC. Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis. J Clin Invest 114: 521–528, 2004.
58. Wang HH, Portincasa P, Liu M, Tso P, Samuelson LC, Wang DQ. Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice. Biochim Biophys Acta 1801: 138–146, 2010.
59. Wostmann BS. Germfree and Gnotobiotic Animal Models: Background and Applications. Boca Raton, FL: CRC, 1996, p. 19–41, 54–57.
60. Xiao ZL, Chen Q, Biancani P, Behar J. Abnormalities of gallbladder muscle associated with acute inflammation in guinea pigs. Am J Physiol Gastrointest Liver Physiol 281: G490–G497, 2001.
61. Xie M, Kotecha VR, Andrade JD, Fox JG, Carey MC. Augmented cholesterol absorption and sarcolemmal sterol enrichment slow small intestinal transit in mice, contributing to cholesterol cholelithogenesis. J Physiol 590: 1811–1824, 2012.